Clinical Trials Browser

Melanoma × Fulvestrant × 90 days × Clear all

NCT07340619 2026-05-19

EPIBREAST

Phase 2 Not yet recruiting

Melanoma, Neoplasm Metastasis

NCT07287917 2026-05-12

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Phase 1/2 Recruiting

BreastDermatologic

Breast Neoplasms, Melanoma